A Brief Version of the LASSI-L Detects Prodromal Alzheimer's Disease States

被引:3
|
作者
Crocco, Elizabeth [1 ,2 ]
Curiel-Cid, Rosie E. [1 ,2 ]
Kitaigorodsky, Marcela [1 ]
Gonzalez-Jimenez, Christian J. [1 ]
Zheng, Diane [1 ]
Duara, Ranjan [2 ,3 ]
Loewenstein, David A. [1 ,2 ]
机构
[1] Univ Miami, Miller Sch Med, Ctr Cognit Neurosci & Aging, Dept Psychiat & Behav Sci, Miami, FL 33136 USA
[2] 1Florida Alzheimers Dis Res Ctr, Miami, FL USA
[3] Mt Sinai Med Ctr, Wien Ctr Alzheimers Dis & Memory Disorders, Miami, FL USA
关键词
Amyloid; biomarkers; cognitive screening; intrusion errors; mild cognitive impairment; neuroimaging; preclinical Alzheimer's disease; semantic interference; structural MRI; MILD COGNITIVE IMPAIRMENT; PROACTIVE SEMANTIC INTERFERENCE; ADAS-COG; DEMENTIA; RESPONSIVENESS; VALIDATION; GUIDELINES; RECOVERY; REGIONS; MEMORY;
D O I
10.3233/JAD-200790
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The Loewenstein-Acevedo Scales for Semantic Interference and Learning (LASSI-L) is an increasingly utilized cognitive stress test designed to identify early cognitive changes associated with incipient neurodegenerative disease. Objective: To examine previously derived cut-points for cognitively unimpaired older adults that were suggestive of performance impairment on multiple subscales of the LAS SI-L. These cut-points were applied to a new sample of older adults who were cognitive healthy controls (HC: n= 26) and those on the Alzheimer's disease (AD) continuum from early stage mild cognitive impairment (EMCI: n= 28), late stage MCI (LMCI: n= 18) to mild AD (AD: n= 27). Methods: All participants were administered the LAS SI-L. All cognitively impaired participants were PET amyloid positive which likely reflects underlying AD neuropathology, while cognitively normal counterparts were deemed to have amyloid negative scans. Results: There was a monotonic relationship between the number of deficits on LAS SI-L subscales and independent classification of study groups with greater severity of cognitive impairment. Importantly, taken together, impairment on maximum learning ability and measures of proactive semantic interference (both reflected by cued recall and intrusion errors) correctly classified 74.1% of EMCI, 94.4% of LMCI, and 96.3% of AD. Only 7.7% of HC were incorrectly classified as having impairments. Conclusion: A modest number of LASSI-L subscales taking approximately 8 minutes to administer, had excellent discriminative ability using established cut-offs among individuals with presumptive stages of AD. This has potential implications for both clinical practice and clinical research settings targeting AD during early prodromal stages.
引用
收藏
页码:789 / 799
页数:11
相关论文
共 50 条
  • [21] Brainstem substructures and cognition in prodromal Alzheimer's disease
    Dutt, Shubir
    Li, Yanrong
    Mather, Mara
    Nation, Daniel A.
    BRAIN IMAGING AND BEHAVIOR, 2021, 15 (05) : 2572 - 2582
  • [22] Biomarkers and Functional Decline in Prodromal Alzheimer's Disease
    Robb, Catherine
    Udeh-Momoh, Chinedu
    Wagenpfeil, Stefan
    Schoepe, Jakob
    Alexopoulos, Panagiotis
    Perneczky, Robert
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 58 (01) : 69 - 78
  • [23] Exploring Alzheimer's disease subtypes at the prodromal stage
    Kolanko, Magdalena A.
    Malhotra, Paresh A.
    BRAIN, 2018, 141 : 3285 - 3287
  • [24] Neuropsychological assessment in preclinical and prodromal Alzheimer's disease
    Nikolai, Tomas
    INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2024, 59 : 453 - 453
  • [25] Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease
    Egan, Michael F.
    Kost, James
    Voss, Tiffini
    Mukai, Yuki
    Aisen, Paul S.
    Cummings, Jeffrey L.
    Tariot, Pierre N.
    Vellas, Bruno
    van Dyck, Christopher H.
    Boada, Merce
    Zhang, Ying
    Li, Wen
    Furtek, Christine
    Mahoney, Erin
    Mozley, Lyn Harper
    Mo, Yi
    Sur, Cyrille
    Michelson, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (15): : 1408 - 1420
  • [26] Brainstem substructures and cognition in prodromal Alzheimer’s disease
    Shubir Dutt
    Yanrong Li
    Mara Mather
    Daniel A. Nation
    Brain Imaging and Behavior, 2021, 15 : 2572 - 2582
  • [27] A Case of Minimally Progressive Prodromal Alzheimer's Disease
    Rosenbloom, Michael H.
    Barclay, Terry
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2023, 7 (01) : 37 - 40
  • [28] Cognitive decline in the prodromal phase of Alzheimer's disease
    Orgogozo, J. -M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 24 - 24
  • [29] Auditory system dysfunction in Alzheimer disease and its prodromal states: A review
    Swords, Gabriel M.
    Nguyen, Lydia T.
    Mudar, Raksha A.
    Llano, Daniel A.
    AGEING RESEARCH REVIEWS, 2018, 44 : 49 - 59
  • [30] Disease Tracking Markers for Alzheimer's Disease at the Prodromal (MCI) Stage
    Drago, Valeria
    Babiloni, Claudio
    Bartres-Faz, David
    Caroli, Anna
    Bosch, Beatriz
    Hensch, Tilman
    Didic, Mira
    Klafki, Hans-Wolfgang
    Pievani, Michela
    Jovicich, Jorge
    Venturi, Luca
    Spitzer, Philipp
    Vecchio, Fabrizio
    Schoenknecht, Peter
    Wiltfang, Jans
    Redolfi, Alberto
    Forloni, Gianluigi
    Blin, Olivier
    Irving, Elaine
    Davis, Ceri
    Hardemark, Hans-goran
    Frisoni, Giovanni B.
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 26 : 159 - 199